Gilead PrEP lenacapavir succeeds in Phase 3 trial

Gilead PrEP lenacapavir succeeds in Phase 3 trial

The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters Gilead‘s experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. None of the roughly 2,000 women in the trial who received Gilead’s shot lenacapavir had contracted HIV by … Read more

More U.S. employers covering GLP-1s for weight loss

More U.S. employers covering GLP-1s for weight loss

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. The injectable weight loss medication Wegovy at New City Halstead Pharmacy in Chicago on April 24, 2024. Scott Olson | Getty Images Good morning! More U.S. employers are covering a buzzy class of medications called GLP-1s for weight … Read more

FDA approves Merck pneumococcal disease vaccine designed for adults

FDA approves Merck pneumococcal disease vaccine designed for adults

Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved Merck‘s new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia, the drugmaker said. Merck’s shot, called Capvaxive, specifically protects against 21 strains … Read more

Eli Lilly CFO Anat Ashkenazi on managing soaring demand for GLP-1s

Eli Lilly CFO Anat Ashkenazi on managing soaring demand for GLP-1s

A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023.  George Frey | Bloomberg | Getty Images Skyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new heights over the last year. … Read more

The 4 things we’re most focused on in the stock market this week

The 4 things we’re most focused on in the stock market this week

The Nasdaq Composite inched higher Friday to claim its fifth straight record close, as new data this past week showed a continued cooling of inflation and Treasury yields retreated. For the week: The tech-heavy Nasdaq gained 3.2%, while the S & P 500 rose 1.6% and the Dow Jones Industrial Average fell 0.5%. Economic updates … Read more

Google-backed Tempus AI pops by as much as 15% in Nasdaq debut

Google-backed Tempus AI pops by as much as 15% in Nasdaq debut

Tempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help physicians provide more accurate treatment for their patients, rose by as much as 15% in its Nasdaq Stock Market trading debut on Friday, after going public under the ticker symbol “TEM.” Tempus AI priced 11.1 million shares at $37 apiece … Read more

9 stocks that can benefit from Fed interest rate cuts

9 stocks that can benefit from Fed interest rate cuts

The S & P 500 and Nasdaq extended their record rallies this week following cooler-than-expected consumer inflation data Wednesday morning. While Fed rate cuts would likely benefit the overall stock market, several names in the CNBC Investing Club portfolio — from housing plays to autos to biotech — could really get a boost. Connecting the … Read more

What we know about the next round of Covid vaccines

What we know about the next round of Covid vaccines

New vaccine COMIRNATY® (COVID-19 Vaccine, mRNA) by Pfizer, available at CVS Pharmacy in Eagle Rock, CA.  Irfan Khan | Los Angeles Times | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! It’s almost that time of the year again. A new … Read more

GLP-1 weight loss boom spurs protein sales, Vitamin Shoppe says

GLP-1 weight loss boom spurs protein sales, Vitamin Shoppe says

The weight loss boom is pushing consumers to spend more on protein supplement products. That’s according to new data from The Vitamin Shoppe’s 2024 Health & Wellness Trend Report, an annual study of 2,000 Americans that provides insight into top consumer trends in the nutritional supplements industry. As more Americans take weight loss treatments like … Read more

FDA advisors recommend Eli Lilly Alzheimer’s drug donanemab

FDA advisors recommend Eli Lilly Alzheimer’s drug donanemab

Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty … Read more